Is the U.S. Military intentionally ordering the bare minimum of Pfizer’s FDA-approved COMIRNATY “vaccine”—legally mandated for all military personnel—while administering the experimental Emergency Use Authorization (EUA) Pfizer mRNA jab to service members as a general rule? It would certainly seem so based on a copy of an internal email dated May 25, 2022, titled “MTF Ordering Guidance for Pfizer Comirnaty-labeled (Tris/Sucrose?Gray Cap) vaccine,” shared by The Colonel’s Corner Telegram page.
The email, addressed to Certified Surgical Technologists (CSTs), provides specific ordering instructions for Military Treatment Facilities (MTFs) related to the “Pfizer/Comirnaty” vaccine with a gray cap. The email states, “Due to the amount of Pfizer Purple Cap vaccine currently on hand, MTFs should limit ordering the Pfizer Gray cap vaccine unless absolutely necessary by the following guidance.”
Specifying the guidance, the email continues, adding that before ordering the “Pfizer Comirnaty-labeled Gray Cap vaccine,” MTFs must first continue to use, order, and exhaust all stock of Purple Cap vaccines. However, they state the following exception:
“If the Pfizer Comirnaty-labeled (gray cap) vaccine is needed due to legal reasons (i.e., mandated), then MTFs will only order the minimum amount needed to fulfill the requirement … “
Despite government agencies repeatedly blurring the lines between Pfizer’s two experimental mRNA COVID-19 “vaccines,” the military’s MTF guidance in the email suggests that the Gray Cap is indeed the COMIRNATY “vaccine.” As previously reported by UncoverDC related to the lawsuit Church v. Biden, the legal distinction between the two jabs—the EUA administered Pfizer-BioNTech COVID-19 Vaccine and FDA Approved COMIRNATY—is significant.
Yet, remarkably, both the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) make no apparent effort to properly differentiate between the two “vaccines,” nor do they explain which one has a Gray Cap and which one has a Purple Cap. Still, as rep…